Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial
- Resource Type
- Article
- Authors
- Shi, W.; Jiang, T.; Nuciforo, P.; Hatzis, C.; Holmes, E.; Harbeck, N.; Sotiriou, C.; Peña, L.; Loi, S.; Rosa, D.D.; Chia, S.; Wardley, A.; Ueno, T.; Rossari, J.; Eidtmann, H.; Armour, A.; Piccart-Gebhart, M.; Rimm, D.L.; Baselga, J.; Pusztai, L.
- Source
- In Annals of Oncology January 2017 28(1):128-135
- Subject
- Language
- ISSN
- 0923-7534